
Marksans Pharma Limited has informed the Exchange regarding a press release dated April 18, 2024, titled "USFDA inspection at Company's manufacturing facility in Verna, Goa, India".
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated April 18, 2024, titled "USFDA inspection at Company's manufacturing facility in Verna, Goa, India".
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma